Comparison of the Risk of Severe Complications of Urinary Tract Infections (UTI) Between Patients With Type 2 Diabetes Exposed to Dapagliflozin and Those Exposed to Other Antidiabetic Treatments

15/01/2016
02/07/2024
EU PAS number:
EUPAS12113
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data source(s)

Data sources (types)

Administrative healthcare records (e.g., claims)
Drug dispensing/prescription data
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.